Testing effectiveness (Phase 2)UnknownNCT01142011What this trial is testingBelimumab in Treating Symptomatic Waldenstroms MacroglobulinaemiaWho this might be right forSymptomatic Waldenstroms Macroglobulinaemia Cancer Trials Australia 15